By measuring specific molecules associated with the pathophysiology of COVID‐19, such as IL‐6 and HBP, inflammatory molecule profiles provide more specific information about the immune dysregulation driving COVID‐19 severity, offering insights that generalized metrics like SII and SIRI cannot. This evidence concerns the gene IL6 and COVID-19.